The present invention provides 4H 6H 5 oxa 2 3 10b triaza benzo[e]azulenes which act as V1a receptor modulators and in particular as Via receptor antagonists their manufacture pharmaceutical compositions containing them and their use as medicaments. The active compounds of the present invention are useful as therapeutics acting peripherally and centrally in the conditions of dysmenorrhea male or female sexual dysfunction hypertension chronic heart failure inappropriate secretion of vasopressin liver cirrhosis nephrotic syndrome anxiety depressive disorders obsessive compulsive disorder autistic spectrum disorders schizophrenia and aggressive behavior.